Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Change in Cash (2016 - 2025)

Historic Change in Cash for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to -$12.3 million.

  • Wave Life Sciences' Change in Cash fell 10780.29% to -$12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$114.7 million, marking a year-over-year decrease of 16703.73%. This contributed to the annual value of $101.8 million for FY2024, which is 903.09% down from last year.
  • Per Wave Life Sciences' latest filing, its Change in Cash stood at -$12.3 million for Q3 2025, which was down 10780.29% from -$34.6 million recorded in Q2 2025.
  • Over the past 5 years, Wave Life Sciences' Change in Cash peaked at $157.0 million during Q3 2024, and registered a low of -$88.9 million during Q1 2022.
  • Moreover, its 5-year median value for Change in Cash was -$19.4 million (2024), whereas its average is $624526.3.
  • Per our database at Business Quant, Wave Life Sciences' Change in Cash soared by 140883.92% in 2022 and then plummeted by 20387.37% in 2025.
  • Quarter analysis of 5 years shows Wave Life Sciences' Change in Cash stood at $26.7 million in 2021, then crashed by 131.69% to -$8.5 million in 2022, then skyrocketed by 815.0% to $60.4 million in 2023, then crashed by 114.66% to -$8.9 million in 2024, then crashed by 38.34% to -$12.3 million in 2025.
  • Its Change in Cash stands at -$12.3 million for Q3 2025, versus -$34.6 million for Q2 2025 and -$59.0 million for Q1 2025.